Impaired Plasma Phenytoin Binding in Uremia
- 1 January 1980
- journal article
- research article
- Published by S. Karger AG in Nephron
- Vol. 25 (5), 231-237
- https://doi.org/10.1159/000181845
Abstract
Phenytoin binding to uremic plasma was studied in vitro. Inhibition of binding independent of albumin concentration was demonstrated. Acidification from pH 8 to pH 3 produced a small decrease in binding by normal plasma but no change or a small increase in binding by uremic plasma. After plasma was acidified to pH 3.0, passed through an anion-exchange resin and realkalinized to pH 8, the binding by uremic plasma was restored to near normal. The uremic abnormality causing impaired plasma drug binding is reversible and supports the concept that a competing ligand, tightly bound at physiologic pH, is responsible for impaired drug binding.This publication has 9 references indexed in Scilit:
- Alteration of plasma albumin in relation to decreased drug binding in uremiaClinical Pharmacology & Therapeutics, 1977
- Solubility and Ionization Characteristics of PhenytoinJournal of Pharmaceutical Sciences, 1977
- Protein binding of salicylate in uremic and normal plasmaClinical Pharmacology & Therapeutics, 1976
- Impaired plasma protein binding of phenytoin in uremia and displacement effect of salicylic acidClinical Pharmacology & Therapeutics, 1976
- CORRECTION OF PROTEIN-BINDING DEFECT IN UREMIC SERA BY CHARCOAL TREATMENT1976
- Serum AlbuminPublished by Elsevier ,1975
- Removal of Fatty Acids from Serum Albumin by Charcoal TreatmentJournal of Biological Chemistry, 1967
- The Specific Binding of l-Tryptophan to Serum AlbuminJournal of Biological Chemistry, 1958
- STUDIES IN SERUM PROTEINS .5. A RAPID PROCEDURE FOR THE ESTIMATION OF TOTAL PROTEIN, TRUE ALBUMIN, TOTAL GLOBULIN, ALPHA-GLOBULIN, BETA-GLOBULIN AND GAMMA-GLOBULIN IN 1.0 ML OF SERUM1948